AllianceBernstein’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $59.3M | Sell |
278,203
-10,389
| -4% | -$2.33M | 0.02% | 550 |
|
|
2025
Q4 | $61.5M | Sell |
288,592
-87,307
| -23% | -$18M | 0.02% | 562 |
|
|
2025
Q3 | $74.7M | Sell |
375,899
-1,802
| -0.5% | -$336K | 0.02% | 513 |
|
|
2025
Q2 | $65.2M | Sell |
377,701
-54,397
| -13% | -$8.86M | 0.02% | 539 |
|
|
2025
Q1 | $67.3M | Sell |
432,098
-12,930
| -3% | -$1.85M | 0.02% | 497 |
|
|
2024
Q4 | $61.3M | Sell |
445,028
-9,760
| -2% | -$1.28M | 0.02% | 538 |
|
|
2024
Q3 | $67.9M | Sell |
454,788
-20,213
| -4% | -$2.73M | 0.02% | 523 |
|
|
2024
Q2 | $64.8M | Buy |
475,001
+1,248
| +0.3% | +$170K | 0.02% | 535 |
|
|
2024
Q1 | $71.6M | Sell |
473,753
-115,183
| -20% | -$16.4M | 0.03% | 504 |
|
|
2023
Q4 | $74.2M | Sell |
588,936
-13,938
| -2% | -$1.39M | 0.03% | 486 |
|
|
2023
Q3 | $56.5M | Buy |
602,874
+24,487
| +4% | +$2.29M | 0.02% | 526 |
|
|
2023
Q2 | $51.6M | Buy |
578,387
+63,329
| +12% | +$5.51M | 0.02% | 565 |
|
|
2023
Q1 | $55.2M | Buy |
515,058
+25,112
| +5% | +$2.87M | 0.02% | 536 |
|
|
2022
Q4 | $59.8M | Sell |
489,946
-149,930
| -23% | -$17.4M | 0.03% | 521 |
|
|
2022
Q3 | $66.1M | Sell |
639,876
-43,920
| -6% | -$4.16M | 0.03% | 471 |
|
|
2022
Q2 | $63.6M | Sell |
683,796
-25,085
| -4% | -$2.36M | 0.03% | 496 |
|
|
2022
Q1 | $83.2M | Sell |
708,881
-1,271
| -0.2% | -$147K | 0.03% | 456 |
|
|
2021
Q4 | $95.5M | Buy |
710,152
+152,221
| +27% | +$22.6M | 0.03% | 453 |
|
|
2021
Q3 | $88.9M | Sell |
557,931
-24,467
| -4% | -$3.35M | 0.04% | 456 |
|
|
2021
Q2 | $76.6M | Buy |
582,398
+103,056
| +21% | +$13.7M | 0.03% | 512 |
|
|
2021
Q1 | $61.8M | Buy |
479,342
+16,809
| +4% | +$2.55M | 0.03% | 541 |
|
|
2020
Q4 | $77.1M | Sell |
462,533
-5,968
| -1% | -$987K | 0.04% | 453 |
|
|
2020
Q3 | $72.3M | Buy |
468,501
+21,467
| +5% | +$3.09M | 0.04% | 432 |
|
|
2020
Q2 | $66.1M | Sell |
447,034
-56,223
| -11% | -$7.72M | 0.04% | 452 |
|
|
2020
Q1 | $56.7M | Sell |
503,257
-33,829
| -6% | -$4.4M | 0.04% | 405 |
|
|
2019
Q4 | $74.7M | Buy |
537,086
+1,940
| +0.4% | +$216K | 0.04% | 417 |
|
|
2019
Q3 | $51.5M | Buy |
535,146
+31,741
| +6% | +$3.54M | 0.03% | 516 |
|
|
2019
Q2 | $58M | Sell |
503,405
-107,449
| -18% | -$12.9M | 0.04% | 499 |
|
|
2019
Q1 | $71.9M | Sell |
610,854
-75,790
| -11% | -$6.64M | 0.05% | 410 |
|
|
2018
Q4 | $43M | Sell |
686,644
-27,722
| -4% | -$1.74M | 0.03% | 520 |
|
|
2018
Q3 | $50.6M | Buy |
714,366
+19,039
| +3% | +$1.31M | 0.03% | 517 |
|
|
2018
Q2 | $46.3M | Sell |
695,327
-38,056
| -5% | -$2.5M | 0.03% | 539 |
|
|
2018
Q1 | $48M | Buy |
733,383
+677,843
| +1,220% | +$38.1M | 0.03% | 496 |
|
|
2017
Q4 | $2.23M | Buy |
55,540
+25,540
| +85% | +$929K | ﹤0.01% | 1780 |
|
|
2017
Q3 | $1.09M | Buy |
+30,000
| New | +$861K | ﹤0.01% | 2235 |
|
Other funds holding ASND
RCM
ACA
AllianceBernstein's ASND Position: Q1 2026 in Review
AllianceBernstein reduced its Ascendis Pharma A/S (ASND) stake by 3.6% in Q1 2026, selling an estimated $2.33M and leaving 278,203 shares worth $59.3M. The position accounts for 0.02% of the portfolio, ranked #550.
AllianceBernstein first reported a position in ASND in Q3 2017 and has held it in 35 quarters since. The position peaked at $95.5M in Q4 2021. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.
- AllianceBernstein held 278,203 shares of Ascendis Pharma A/S worth $59.3M as of Q1 2026.
- AllianceBernstein sold 10,389 Ascendis Pharma A/S shares in Q1 2026, an estimated $2.33M.
- Ascendis Pharma A/S made up 0.02% of AllianceBernstein's portfolio in Q1 2026, its #550 holding.
- AllianceBernstein first reported a position in Ascendis Pharma A/S in Q3 2017 and has held it in 35 quarters since.
- AllianceBernstein's Ascendis Pharma A/S position peaked at $95.5M in Q4 2021.
- 273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.